NV-31
N/A
Report date: 2022/09/28 20:01:03
NME
Base Information
Drug NameNV-31
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDr. Willmar Schwabe
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesDr. Willmar SchwabeUniversity Of Marburg
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A